This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Primerica Shares Up Since Q1 Earnings Surpass Estimates
by Zacks Equity Research
PRI stock edges up after Q1 earnings beat estimates, with strong sales across key segments despite rising benefits and expenses.
Houlihan Lokey Shares Up Since Q4 Earnings Beat Estimates
by Zacks Equity Research
HLI shares climb 5.4% after Q4 earnings beat, driven by strong segment growth and higher revenues despite rising expenses.
eHealth Shares Down 2.4% Despite Q1 Earnings Beat, '25 View Reaffirmed
by Zacks Equity Research
EHTH continues to witness growth in Medicare submissions across the core agency and carrier-dedicated Amplify platforms.
EG Stock Trading at a Discount to Industry at 1.02X: Time to Hold?
by Zacks Equity Research
Everest Group remains poised to gain from strong renewal retention, continued favorable rate increases and prudent capital deployment.
RDN Boosts Shareholder Value, Okays Buyback Program Worth $750M
by Zacks Equity Research
Radian Group's latest repurchase authorization reflects its intention to enhance shareholder value, which is supported by its strong financial position.
Corebridge Stock Up 7.6% Since Q1 Earnings Beat Estimates
by Zacks Equity Research
CRBG witnesses a decline in group retirement premiums and deposits. It paid quarterly dividends of $133 million.
Employers Holdings' Stock Up 4.2% Since Q1 Earnings Beat Estimates
by Zacks Equity Research
EIG continues to witness growth in net investment income. It authorizes a new $125 million share repurchase program.
Wall Street Analysts Think EverQuote (EVER) Could Surge 42.43%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 42.4% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
4 Stocks Showing Strong Relative Price Strength Right Now
by Nilanjan Choudhury
GLDD, SFM, EVER and EHC are four stocks with explosive relative price strength.
Rithm Capital Q1 Earnings Beat Estimates, Stock Up 12.2%
by Zacks Equity Research
RITM continues to witness growth in originated residential mortgage loans held for sale, net. It paid a quarterly dividend of 25 cents per share in Q1.
Equitable Holdings Q1 Earnings Miss Estimates, Stock Up 3.5%
by Zacks Equity Research
EQH returns $74 million as cash dividends and $261 million as share repurchases in the first quarter of 2025.
Regional Management's Q1 Earnings Beat Estimates, Stock Dips 11.6%
by Zacks Equity Research
RM continues to witness growth in loan originations. RM bought back shares worth $6.5 million in the first quarter of 2025.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Encore Capital Q1 Earnings Top Estimates on Higher Portfolio Purchases
by Zacks Equity Research
ECPG continues to witness growth in global collections. It repurchases shares worth $10 million in the first quarter of 2025.
Zacks.com featured highlights Avino Silver & Gold Mines, Pagaya, EverQuote and Sezzle
by Zacks Equity Research
Avino Silver & Gold Mines, Pagaya, EverQuote and Sezzle have been highlighted in this Screen of The Week article.
4 Top-Ranked Liquid Stocks to Bet on for Boosting Portfolio Returns
by Vaishali Doshi
Investors can boost returns by adding top-ranked liquid stocks such as Avino Silver, Pagaya Technologies, EverQuote and Sezzle to their portfolios.
ProAssurance Q1 Earnings Miss Estimates on Declining Premiums
by Zacks Equity Research
PRA reports continued growth in net investment income in the first quarter of 2025.
MGIC Investment Corporation (MTG) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
MGIC (MTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EverQuote's Q1 Earnings & Revenues Beat, Automotive Vertical Grows
by Zacks Equity Research
EVER's first-quarter results mark the fourth straight quarter of record revenue and adjusted EBITDA performance. All the verticles showed improvement.
EverQuote (EVER) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for EverQuote (EVER) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EverQuote (EVER) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 18.75% and 5.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
CNO Q1 Earnings Meet Estimates on Higher Collected Premiums
by Zacks Equity Research
CNO affirms operating EPS to be in the range of $3.70-$3.90 and excess cash flow in the range of $200-$250 million.
EverQuote Gears Up to Report Q1 Earnings: What to Expect
by Zacks Equity Research
EVER's first-quarter results are likely to reflect benefit from auto insurance and homeowners' insurance market recovery, as well as improved operational efficiency.
ROOT Stock Surges 109% YTD, Drops 16% From 52-Week High: Time to Buy?
by Tanuka De
ROOT envisions being the largest and most profitable company in the industry. Let us delve deeper to find out what to do with ROOT stock now.